1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers

Trial Profile

1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Jan 2018

At a glance

  • Drugs Varenicline (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jan 2018 New trial record
    • 20 Dec 2017 Primary endpoint (Percentage of heavy drinking days during the last 8 weeks of treatment) has not been met as per the results published in the JAMA Psychiatry
    • 20 Dec 2017 Results (data cut off August 31, 2015) assessing safety and efficacy published in the JAMA Psychiatry
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top